Low-dose Naltrexone for atopic dermatitis? (News)

Low-dose Naltrexone for atopic dermatitis? National Eczema Association 11 April 2019 https://nationaleczema.org/naltrexone/ Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disorders, affecting up to 20 percent of children and 10 percent of adults. The main goals of treatment are to decrease itching and pain, dampen the skin inflammation, repair the skin […]

Prurigo excoriée treated with low dose naltrexone (Abstract)

Prurigo excoriée treated with low dose naltrexone BMJ Case Rep 19 November 2021 https://pubmed.ncbi.nlm.nih.gov/34799388/ A 53-year-old woman presented with a 25-year history of acne excoriée and prurigo excoriée. Her symptoms began in 1988 coinciding with her husband’s death from a brain tumour when she was 27. The pruritus affected her quality of life and disturbed […]

Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Condition… (Abstract)

Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review JAMA Dermatol 01 February 2019 https://pubmed.ncbi.nlm.nih.gov/30484835/ Importance: Dermatology is encountering increasing rates of autoimmune disease manifesting in primary skin conditions that are difficult to treat without a risk of immunosuppression. Naltrexone is an orally active opioid antagonist that influences a variety of systemic […]

The uses of naltrexone in dermatologic conditions (Abstract)

The uses of naltrexone in dermatologic conditions J Am Acad Dermatol June 2019 https://pubmed.ncbi.nlm.nih.gov/30582992/ Background: Naltrexone in standard and reduced doses is efficacious in many inflammatory and acantholytic disorders. Objective: We summarized the current data of naltrexone that are relevant to dermatologic practice. Methods: An English language PubMed literature search was performed using the terms […]

The Use of Naltrexone in Dermatology. Current Evidence and Future Directions (Abstract)

The Use of Naltrexone in Dermatology. Current Evidence and Future Directions Curr Drug Targets 2019 https://pubmed.ncbi.nlm.nih.gov/30887922/ Naltrexone is a competitive opioid receptor antagonist approved as supportive treatment in alcohol dependence and opioid addiction. At a dose of 50-100 mg daily, naltrexone is used off-label in dermatology for the treatment of trichotillomania and different types of […]